喘和COPD:关注β-抗原剂 - 过去,现在和未来的焦点
Jillian G Baker1,2, Dominick E Shaw3
1Department of Respiratory Medicine, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK. Jillian.Baker@nottingham.ac.uk.
Handbook of experimental pharmacology
|September 14, 2023
概括
本综述详细介绍了喘和慢性阻塞性肺病 (COPD) 的β-激素治疗方法的演变,追踪了从早期上腺素使用到现代选择性和长效药物的进展.
科学领域:
- 药理学和呼吸系统医学
- 药物开发和治疗学
背景情况:
- 喘和慢性阻塞性肺病 (COPD) 是全球重要的健康问题,影响着全球数百万人.
- 针对喘的向药物开发有120年的历史,而COPD则造成了相当大的经济和社会负担.
- 贝塔激动剂对于管理这些呼吸系统疾病至关重要.
研究的目的:
- 审查beta-agonist治疗喘和COPD的历史发展.
- 分析从早期上腺素隔离到当前一代短效和长效β-agonists的进展.
- 检查提高选择性和作用持续时间对治疗疗效和指导方针的影响.
主要方法:
- 关于beta-agonist开发中的药理学进展的历史审查.
- 对临床化合物的分析,包括不再使用的化合物.
- 检查药理性质及其对治疗指南的影响.
主要成果:
- 贝塔激动剂的进化导致了喘和COPD管理的显著改善.
- 一代又一代的β-agonists在选择性和作用持续时间方面取得了进展.
- 了解不同β2-激动剂的特性,可以了解它们在治疗指南中的当前位置.
结论:
- 贝塔激动剂的开发改变了喘和COPD的治疗环境.
- 未来的发展旨在进一步提高β-agonist的疗效和可访问性.
- 在服务不足的地区扩大获得先进呼吸道药物的机会是未来的一个关键目标.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
241
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
241
Antiasthma Drugs: β2-Adrenoceptor Agonists
295
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
295
Drugs Used in Lower Respiratory Disorders: Overview
481
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
481
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma: Pathogenesis and Management
439
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
439
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
332
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
332


